ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Research Institute Goes To Wall Street

January 17, 1986

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

DCE Board Approves concepts For Grants to Develop HPV Animal Models, ALL Etiology Contracts

March 11, 1988

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

ASCO To Open Abstracts To Everyone Prior To Annual Meeting.

November 16, 2007